XBiotech (XBIT) Retained Earnings (2014 - 2026)
XBiotech (XBIT) posted quarterly Retained Earnings of -$136.4 million for Q4 2025, down 50.13% year-over-year from -$273.5 million in Q4 2024, and down 24.56% quarter-over-quarter from -$109.5 million in Q3 2025.
XBiotech (XBIT) Retained Earnings (2014 - 2026) Analysis & Trends
XBiotech's Retained Earnings history runs 12 years deep, the most recent figure standing at -$136.4 million for Q4 2025.
- In Q4 2025, Retained Earnings fell 50.13% year-over-year to -$136.4 million; the TTM figure through Dec 2025 stood at -$136.4 million (down 50.13% YoY), while the FY2025 annual figure was -$136.4 million, down 50.13% from the prior year.
- Retained Earnings for Q4 2025 stood at -$136.4 million, down from -$109.5 million in the prior quarter.
- The five-year high for Retained Earnings was $95.0 million in Q1 2021, with the low at -$136.4 million in Q4 2025.
- The 5-year median for Retained Earnings is -$29.7 million (2022), against an average of -$39.7 million.
- The sharpest annual moves came in 2021 and 2024: Retained Earnings surged 593850.0% in 2021, then slumped 18356.59% in 2024.
- XBiotech's Retained Earnings stood at $5.2 million in 2021, then plunged by 638.71% to -$27.7 million in 2022, then tumbled by 88.5% to -$52.3 million in 2023, then sank by 73.66% to -$90.8 million in 2024, then plunged by 50.13% to -$136.4 million in 2025.
- Business Quant data shows XBIT's Retained Earnings at -$136.4 million in Q4 2025, -$109.5 million in Q3 2025, and -$103.5 million in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Retained Earnings (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | 15.69 Bn |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | 37.62 Bn |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | 558.00 Mn |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | 5.10 Bn |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | 13.05 Bn |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | -6.33 Bn |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | 6.57 Bn |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | 4.38 Bn |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | 20.91 Bn |
| 10 | XBiotech | 68.90 Mn | 68.90 Mn | - | -148.61 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -148.61 Mn |
| Dec 31, 2025 | -136.38 Mn |
| Sep 30, 2025 | -109.49 Mn |
| Jun 30, 2025 | -103.48 Mn |
| Mar 31, 2025 | -101.72 Mn |
| Dec 31, 2024 | -90.84 Mn |
| Sep 30, 2024 | -80.33 Mn |
| Jun 30, 2024 | -75.31 Mn |
| Mar 31, 2024 | -62.31 Mn |
| Dec 31, 2023 | -52.31 Mn |
| Sep 30, 2023 | 440,000.00 |
| Jun 30, 2023 | 440,000.00 |
| Mar 31, 2023 | -31.57 Mn |
| Dec 31, 2022 | -27.75 Mn |
| Sep 30, 2022 | -24.55 Mn |
| Jun 30, 2022 | -11.89 Mn |
| Mar 31, 2022 | -244,000.00 |
| Dec 31, 2021 | 5.15 Mn |
| Sep 30, 2021 | 11.62 Mn |
| Jun 30, 2021 | 1.90 Mn |